News

Why did Lilly data for oral GLP-1 boost Structure and Metsera?
Structure Therapeutics (GPCR) stock and Metsera (MTSR) stock soar as Eli Lilly (LLY) reports promising Phase 3 results for ...
Why did Lilly data for oral obesity drug boost Structure and Metsera?
Obesity drug developers Structure Therapeutics (NASDAQ:GPCR) and Metsera (NASDAQ:MTSR) recorded sharp gains alongside Eli ...
SA Asks: What's the best weight-loss drug stock right now?
Shares of obesity drug developers were volatile this week amid good news for Eli Lilly's (LLY) drug candidate orforglipron, ...
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
Guggenheim downgraded Novo Nordisk (NVO) to Neutral from Buy.Stay Ahead of the Market: Discover outperforming stocks and invest smarter with ...
MarketWatch16h
Dow Jones U.S. Total Stock Market Index
S&P/TSX Composite Index 24,192.81 86.02 0.36% ...